Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Saunders

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Mabs|February 5, 2014
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockadeKaren Silence, Torsten Dreier, Mahan Moshir, et al.
Scientific Reports|August 23, 2016
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacyMarie Godar, Virginia Morello, Ava Sadi, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Triterpene based compounds with potent anti-maturation activity against HIV-1David Gerrish, In Chul Kim, Dange V Kumar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2020
Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to MethotrexateMichael F Robinson, Nemanja Damjanov, Bojana Stamenkovic, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trialChristopher G Azzoli, Jyoti D Patel, Lee M Krug, et al.
Gastrointestinal Endoscopy|July 4, 2012
Multicenter, randomized, controlled trial of confocal laser endomicroscopy assessment of residual metaplasia after mucosal ablation or resection of GI neoplasia in Barrett's esophagusMichael B Wallace, Julia E Crook, Michael Saunders, et al.
The Journal of Clinical Investigation|May 29, 2014
Four individually druggable MET hotspots mediate HGF-driven tumor progressionCristina Basilico, Anna Hultberg, Christophe Blanchetot, et al.
Sexually Transmitted Infections|September 12, 2021
No widespread dissemination of <i>Chlamydia trachomatis</i> diagnostic-escape variants and the impact of <i>Neisseria gonorrhoeae</i> positivity on the Aptima Combo 2 assayMichelle Jayne Cole, Grahame S Davis, Helen Fifer, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2013
Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2)Yong Xu, Xiao-Hui Liu, Michael Saunders, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|December 30, 2020
Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008-2019)Kim Keltie, Adam Donne, Mat Daniel, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Mabs|February 5, 2014
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockadeKaren Silence, Torsten Dreier, Mahan Moshir, et al.
Scientific Reports|August 23, 2016
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacyMarie Godar, Virginia Morello, Ava Sadi, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Triterpene based compounds with potent anti-maturation activity against HIV-1David Gerrish, In Chul Kim, Dange V Kumar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2020
Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to MethotrexateMichael F Robinson, Nemanja Damjanov, Bojana Stamenkovic, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trialChristopher G Azzoli, Jyoti D Patel, Lee M Krug, et al.
Gastrointestinal Endoscopy|July 4, 2012
Multicenter, randomized, controlled trial of confocal laser endomicroscopy assessment of residual metaplasia after mucosal ablation or resection of GI neoplasia in Barrett's esophagusMichael B Wallace, Julia E Crook, Michael Saunders, et al.
The Journal of Clinical Investigation|May 29, 2014
Four individually druggable MET hotspots mediate HGF-driven tumor progressionCristina Basilico, Anna Hultberg, Christophe Blanchetot, et al.
Sexually Transmitted Infections|September 12, 2021
No widespread dissemination of <i>Chlamydia trachomatis</i> diagnostic-escape variants and the impact of <i>Neisseria gonorrhoeae</i> positivity on the Aptima Combo 2 assayMichelle Jayne Cole, Grahame S Davis, Helen Fifer, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2013
Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2)Yong Xu, Xiao-Hui Liu, Michael Saunders, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|December 30, 2020
Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008-2019)Kim Keltie, Adam Donne, Mat Daniel, et al.
Pageof 9